Aya K. Hegazy

Aya K. Hegazy

Auto-generated profile, based on publicly available information

Aya K. Hegazy

Alexandria University

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2026 in Cephalalgia Reports
Verified
Journal Article
Open access
Mohamed Ibrahim MohamedMohamed Ibrahim Mohamed
Mohamed Ibrahim Mohamed
MSMichael Salib
Michael Salib
AHAya K. Hegazy
Aya K. Hegazy
RSRana Sameh
Rana Sameh
BABasmalla Ashraf
Basmalla Ashraf
Mona NadaMona Nada
Mona Nada
Background: Status migrainosus (SM) is a prolonged migraine attack lasting over 72 hours. Pediatric-specific data on SM remain sparse. Methods: Searches were conducted in six medical databases to July 2025. Eligible studies included clinical trials, cohorts, and case series (≥5 patients) reporting SM. Independent reviewers conducted screening, extraction, and quality appraisal. Results: Of 658 studies, 17 ( n = 7161;1857 pediatric SM cases) were included—predominantly single-center, retrospective studies, without randomized controlled trials. Most SM cohorts showed a female, adolescent (13–16 years) preponderance. SM's management strategies were heterogeneous; with peripheral nerve (PNB) and sphenopalatine ganglion (SPG) blocking procedures (3 studies, 690 patients) and anti-seizure medications (2 studies using valproate, 146 patients) being commonly reported. PNB and SPG blocking procedures were associated with short-term improvement and safety. In one comparative study of 94 patients, lidocaine infusions showed a trend toward faster pain relief and fewer adverse effects than IV valproate. One study of 177 patients directly compared IV dihydroergotamine to PNB, identifying a longer hospital duration of stay among dihydroergotamine recipients but a better response rate. Factors associated with poor response included older age, anxiety, medication overuse, and baseline severity. Among others, self-reported psychological stress was an SM trigger in two studies. Interpretation: Available evidence on SM in pediatric populations remains limited by non-randomized evidence, prone to inherent bias. Consequently, multicenter, comparative, randomized trials are warranted to establish pediatric-specific protocols. Observational evidence suggests that PNB/SPG blocking procedures may offer promise to those with failure of medical management strategies. Trial Registration: This PRISMA-compliant review was prospectively registered on PROSPERO (CRD420251088970).